OTC:RAJAF | EBITDA Margin | TFA Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2022-12-31 to 2023-12-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2023-12-3155.84%

Annual EBITDA Margin

DateEBITDA Margin
2023-12-3132.25%
2022-12-31-732.84%

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.